Canlyniadau Chwilio - Bogenrieder, Thomas
- Dangos 1 - 10 canlyniadau o 10
-
1
-
2
Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies gan Simpson, Aaron, Petnga, Wilfride, Macaulay, Valentine M., Weyer-Czernilofsky, Ulrike, Bogenrieder, Thomas
Cyhoeddwyd 2017Text -
3
Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer gan Ireland, Lucy, Santos, Almudena, Campbell, Fiona, Figueiredo, Carlos, Hammond, Dean, Ellies, Lesley G., Weyer-Czernilofsky, Ulrike, Bogenrieder, Thomas, Schmid, Michael, Mielgo, Ainhoa
Cyhoeddwyd 2018Text -
4
CHK1 inhibition exacerbates replication stress induced by IGF blockade gan Wu, Xiaoning, Seraia, Elena, Hatch, Stephanie B., Wan, Xiao, Ebner, Daniel V., Aroldi, Francesca, Jiang, Yanyan, Ryan, Anderson J., Bogenrieder, Thomas, Weyer-Czernilofsky, Ulrike, Rieunier, Guillaume, Macaulay, Valentine M.
Cyhoeddwyd 2021Text -
5
Regulation of proliferation and invasion by the IGF signalling pathway in Epstein‐Barr virus‐positive gastric cancer gan Jeong, Inhye, Kang, Sun Kyoung, Kwon, Woo Sun, Kim, Hyun Jeong, Kim, Kyoo Hyun, Kim, Hyun Myong, Lee, Andre, Lee, Suk Kyeong, Bogenrieder, Thomas, Chung, Hyun Cheol, Rha, Sun Young
Cyhoeddwyd 2018Text -
6
Phase 1b Open-Label Trial of Afatinib Plus Xentuzumab (BI 836845) in Patients With EGFR Mutation-Positive NSCLC After Progression on EGFR Tyrosine Kinase Inhibitors gan Park, Keunchil, Tan, Daniel Shao Weng, Su, Wu-Chou, Cho, Byoung Chul, Kim, Sang-We, Lee, Ki Hyeong, Wang, Chin-Chou, Seto, Takashi, Huang, Dennis Chin-Lun, Jung, Helen Hayoun, Hsu, Ming-Chi, Bogenrieder, Thomas, Lin, Chia-Chi
Cyhoeddwyd 2021Text -
7
Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors gan Ireland, Lucy, Santos, Almudena, Ahmed, Muhammad S., Rainer, Carolyn, Nielsen, Sebastian R., Quaranta, Valeria, Weyer-Czernilofsky, Ulrike, Engle, Danielle D., Perez-Mancera, Pedro A., Coupland, Sarah E., Taktak, Azzam, Bogenrieder, Thomas, Tuveson, David A., Campbell, Fiona, Schmid, Michael C., Mielgo, Ainhoa
Cyhoeddwyd 2016Text -
8
Nuclear IGF-1R interacts with regulatory regions of chromatin to promote RNA polymerase II recruitment and gene expression associated with advanced tumor stage gan Aleksic, Tamara, Gray, Nicki, Wu, Xiaoning, Rieunier, Guillaume, Osher, Eliot, Mills, Jack, Verrill, Clare, Bryant, Richard J., Han, Cheng, Hutchinson, Kathryn, Lambert, Adam G., Kumar, Rajeev, Hamdy, Freddie C., Weyer-Czernilofsky, Ulrike, Sanderson, Michael P., Bogenrieder, Thomas, Taylor, Stephen, Macaulay, Valentine M.
Cyhoeddwyd 2018Text -
9
A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic bre... gan Schmid, Peter, Sablin, Marie-Paule, Bergh, Jonas, Im, Seock-Ah, Lu, Yen-Shen, Martínez, Noelia, Neven, Patrick, Lee, Keun Seok, Morales, Serafín, Pérez-Fidalgo, J. Alejandro, Adamson, Douglas, Gonçalves, Anthony, Prat, Aleix, Jerusalem, Guy, Schlieker, Laura, Espadero, Rosa-Maria, Bogenrieder, Thomas, Huang, Dennis Chin-Lun, Crown, John, Cortés, Javier
Cyhoeddwyd 2021Text -
10
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours gan de Bono, Johann, Lin, Chia-Chi, Chen, Li-Tzong, Corral, Jesus, Michalarea, Vasiliki, Rihawi, Karim, Ong, Michael, Lee, Jih-Hsiang, Hsu, Chih-Hung, Yang, James Chih-Hsin, Shiah, Her-Shyong, Yen, Chia-Jui, Anthoney, Alan, Jove, Maria, Buschke, Susanne, Fuertig, René, Schmid, Ulrike, Goeldner, Rainer-Georg, Strelkowa, Natalja, Huang, Dennis Chin-Lun, Bogenrieder, Thomas, Twelves, Chris, Cheng, Ann-Lii
Cyhoeddwyd 2020Text